Samer S Najjar
- Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trialSamer S Najjar
Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
JAMA 305:1863-72. 2011..Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function...